Intas Pharmaceuticals To Be The First To Launch Pegfilgrastim Biosimilar In Europe

Pelgraz, - A Pegylated G-CSF Biosimilar, Is The Latest Addition To Its Established Portfolio Of Over 30

Oncology Treatments Across EuropeIntas Pharmaceuticals’ Mob:- 07895445251, 09719125169, 09457249001,07939837000 wholly owned subsidiary - Accord Healthcare is set to be the first integrat-ed player to launch a pegfilgrastim biosimilaracross Europe after being given Green Light forPelgraz® (pegfilgrastim) by CHMP. TheCommittee for Medicinal Products for HumanUse (CHMP) has issued a positive opinion forAccord’s Pelgraz (pegfilgrastim), pegylated gran-

ulocyte-colony stimulating factor (G-CSF) biosimilar in Europe. Current marketfor pegfilgrastim in EU is about half a billion Euro. Intas Pharmaceuticals willmanufacture Pelgraz in its own state of the art production facility. Intas hasdeep experience with biosimilar medicines. As of July 2018 Intas has 12 dif-ferent Biosimiliars approved in various markets across the world. This reflectsa long-standing commitment of Intas to develop, manufacture and marketbiosimilars. The company's dedicated biologic manufacturing plant was thefirst in India to gain and maintain EU GMP approval. Intas started its biosimi-lar program 15 years ago, and has already launched 12 biologics in India.Intas was the first ever Indian company to launch a biosimilar in Europe andtill date remains the only India-based company to have a biosimilar productapproved in European markets. In a short span Intas has garnered about 15% market share for its biological product “Accofil” (Filgrastim) in EU. BinishChudgar Vice Chairman and Managing Director of Intas Group, “Intas/Accordlaunched its first European approved biosimilar product, Accofil, in 2015 anddespite being the 6th entrant has become a leading supplier of this vital med-icine. Since then the product has been used over 2 million times and Intas hasgained valuable experience in bringing biosimilar medicines to market. Ourcontinued focus on bringing biopharmaceuticals to Europe has enabled usto be a first to launch a pegfilgrastim, and as a first mover we expect to gainan even bigger market share with Pelgraz.” Emilio Rivera, COO of IntasBiotech,” At Intas Biotech, our mandate is to develop, manufacture andmarket Biosimiliars of world class quality. We would like our products to beaccessible to as many patients as possible. With this approval it bringsIntas one step closer in realizing its vision of Biosimiliars for Billions.”

For

Advertisement

in

Pharma Darpan

News Paper

Please Call

Mob:-

09410434811

09219176673

09758502423

09319980483

09219444474

08394863910

Dr. Reddy's Laboratories Launches Tadalafil Tablets USP in the U.S.Hyderabad:- Dr. Reddy’s Laboratories Ltd. Mob:- 09058458612, 09307668480,09305955262, 09761760618 along with its subsidiaries together referred to as “Dr. Reddy’s”)today announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic ver-sion of Adcirca (tadalafil) Tablets in the United States market, approved by the U.S. Food andDrug Administration (USFDA). The Adcirca brand and generic had U.S. sales of approximate-ly $490 million MAT for the most recent twelve months ending in November 2018 according

to IMS Health*. Dr. Reddy’s Tadalafil Tablets are available in 20 mg with 60 count bottle size.

Cipla and Wellthy Therapeutics Announce Partnership To OfferDigital Therapeutics For Diabetes And Cardiovascular Diseases

Mumbai:- Cipla Limited Mob:- 09760036888, 09911865532, 09829240002 and WellthyTherapeutics Private Limited (“Wellthy Therapeutics”) today announced that they haveentered into a partnership to offer a combination of pharmacotherapy and digital therapeuticsfor improved patient outcomes in the chronic therapies of diabetology and cardiology. Underthe agreement, a multi-lingual clinically-validated digital disease management platform will bemade available to patients living with diabetes or cardiovascular diseases via doctors’ clinicsor co-packaging on select Cipla brands. The platform brings together behavioural science, realworld clinical evidence and artificial intelligence to provide real time monitoring, coaching and

advice to patients, and virtual clinical assistance to doctors. This partnership is a result of Cipla’s campaign,Innoventia, which was envisioned as a first-of-its-kind challenge by an Indian pharmaceutical company to encour-age innovation-led entrepreneurship and to harness disruptive ideas in healthcare to fulfil unmet patient needs.

Biocon Appoints Dr. Christiane Hamacher as CEO Of BioconBiologics India Limited

Bengaluru:- Biocon Ltd. Mob:- 09811206565, +91 8028082808,

91 8040144014 Asia’s premier biopharmaceuticals company,

announced today that Dr. Christiane Hamacher has been appointed

as CEO of Biocon Biologics India Ltd. effective today. Dr. Hamacher

comes with more than 20 years of leadership experience in both

strategic and operational roles across the value chain in global

pharma, spanning Asia, Europe and the U.S. She has been with

Roche, Basel, Switzerland since 2007 and prior to that spent 10

years at Schering AG, Berlin, Germany. Ms Kiran Mazumdar-Shaw, Chairperson & Managing Director,

Biocon, said: “I am delighted to welcome Christiane Hamacher as CEO of Biocon Biologics India Ltd.

Christiane joins us at a critical inflexion point in the business as we build our stature in the large and

growing opportunity for biosimilar biologics. I am confident that she will successfully lead the company

to become a major global player in the near future. Being a woman leader, I believe she also brings a

diversity perspective which is integral to our leadership journey.” Dr. Hamacher is an accomplished inter-

national C-suite executive with a passion for setting the corporate vision, defining and implementing

future-driven strategy and growing businesses

through entrepreneurial innovation and patient-cen-

tricity. She has robust experience in steering com-

plex, global matrix organizations, quickly building

strong, trusting relationships to enable achievement

of top-level results. During her long career in the

pharmaceutical industry, she has built expertise in

the areas of oncology, virology, CNS, cardiovascu-

lar, gynaecology, diagnostics, dermatology, rheuma-

tology and rare diseases. She holds a Ph.D. in

Molecular Biology (Oncology) from the University

Clinic Bergmannsheil / University of Bochum,

Germany. She also studied Economics at the

University of Hagen, Germany.

osnf'ko fctusl ehfM;k dk iQkekZ iQs;j gqcyh esaizkIr tkudkjh ds vuqlkj fnukad 17 ,oa 18 ebZ 2019 dks osnf'kofctusl ehfM;k izkñfyñ }kjk Shubhodaya Convention Hall,Hubballi (Karnataka) esa ,d iQkekZ iQs;j dk vk;kstu fd;k tkjgk gS- osnf'ko fctusl ehfM;k ls f'koe 'kekZ eksñ 09258002828 usbl lUnHkZ esa tkudkjh nh gS fd bl iQkekZ iQs;j esa lEiw.kZ Hkkjro"kZesa Third Party Manufacturing, PCD vkSj Franchise csfllnok deifu;ksa ds lkFk&lkFk ekdsZfVax dEiuh vkSj vkl&ikl ds nokefUM;ksa ds LVkWfdLV f'kjdr djsxsa- f'koe 'kekZ us ;g Hkh tkudkjhnh gS fd bl iQkekZ esyk esa foftVZl dh ,UVªh izQh gksxh-

mUufr ds iFk ij Chandrayan Herbal & FoodPvt. Ltd.

Jh fouksn feJk eksñ 09098140945 tcyiqj (eñizñ) us ehfM;k gkÅl dks tkudkjh nh gSfd muds ;gk¡ yxHkx lHkh gcZy vkSj iQwM izksMDV~l mÙke DokfyVh esa cuk;s tk jgs gSa-ftuesa fo'ks"k:i ls Femi Active Syrup, Livo Act Syrup,Cardio Act Syrup, Udardoshntak Churna izeq[k gSa- lEiw.kZHkkjro"kZ esa gcZy vkSj iQwM izksMDV~l cuokus gsrq vkSj LVkWfdLV cuusgsrq Jh fouksn feJk th ls lEiZd fd;k tk ldrk gS-

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj esa gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsaA

MkWñ lat;tk;sxsa uhnjySaM

3RD GlobalSummit On oto-l a r y n g o l o g y -2019 esa Hkkx ysusds fy, vk;kstdks aus vgenkckn dsMkWñ lat; vxzokyeksñ 09825381729dks mudh‘Otolaryngology’ ij 'kks/ dsfy, 18&19 uoEcjes a uhnjyS aM es avkefU=kr fd;k gS-

MkWñ lat; vxzoky

L�okbu Ýyw gksus ls igys gh mlds ok;jl dks ekj nsrh gSa;s 5 vkS"kf/;k¡] ugha gksrk laØe.k

vdsys fnYyh ,ulhvkj esa Lokbu Ýyw ds ekeys iQjojh dh 'kq#vkr esa 1000 ds ikj gksx, gSa- dqN yksx vHkh Hkh bl chekjh ls ihfM+r gSa] dqN us bls jksdus ds mik; •ksts-mUgksaus ekLd igus] lgh •kus vkSj nwljksa dks ok;jl ls lqjf{kr jgus tSls mik; fd,-gkykafd jksdFkke bykt ls csgrj gS vkSj chekjh dks jksdus ds fy, blls cpko lcls vPNkrjhdk gS] vxj vki ;k vkids fdlh djhch dks laØe.k ls cpkuk gS rks ;gk¡ Lokbu Ýywdk bykt djus ds fy, nokvksa ds vykok Hkh fodYi gSa] ftuls Lokbu Ýyw ls cpk tkldrk gS- vki bUgsa vius nSfud thou esa 'kkfey djds bl xaHkhj chekjh ls cpko dj ldrs gSa- l yglqu%& yglqu esa ,aVh&baÝykesVªh xq.k ik, tkrs gSa tks 'kjhj esa ,aVhvkWfDlMsaV xfrfof/ dks c<+kok nsrk gS- bldk mi;ksxihB nnZ vkSj fljnnZ ds mipkj esa fd;k tkrk gS vkSj ;g Lokbu Ýyw ds bykt esa Hkh enn dj ldrk gS- yglqu esa ekStwn ,fyflu bE;wfuVh dks csgrj cukrk gS- yglqu dh dqN dfy;ka lqcg xeZ ikuh ds lkFk •kus lsokLro esa enn fey ldrh gS- l rqylh%& rqylh vius vkS"k/h; xq.kksa ds fy, tkuk tkrk gS- jksxksa ls yM+us tSls Ýyw] •k¡lh vkSj BaM dks csvj djus esa iQk;nsean gksrk gS- rqylh dk mi;ksx Lokbu Ýyw ds bykt vkSj rsthls Bhd djus ds fy, fd;k tk ldrk gS- l ftulsax%& ftulsax e/qesg jksfx;ksa dks jÙkQ 'kdZjk dks fu;af=kr djus esa enn djus ds fy, tkuk tkrk gS- gkykafd] ;g Lokbu Ýyw ds bykt esa Hkh enn dj ldrk gS- fofHkUuvè;;u crkrs gSa fd ftulsax H1N1 ok;jl ls yM+us esa enn dj ldrk gS- Lokbu Ýyw ds jksfx;ksa ds fy, ,d di ftulsax pk; dh lykg nh tkrh gS- l gYnh%& Hkkjrh; ?kjksa esa •kuk idkus esa gYnh dks çeq• elkysds :i esa tkuk tkrk gS- gYnh esa ,aVhlsfIVd] ,aVh&baÝysesVjh xq.k gksrs gSa tks Lokbu Ýyw ds bykt esa enn dj ldrs gSa- ,d di xeZ gYnh okyk nw/ ,p1 ,u1 tSls jksxksa] ek¡lisf'k;ksa esa nnZ ;k ?kkrd ok;jl ls yM+us esaenn dj ldrk gS- l tSrwu ds iÙks%& tSrwu ds iÙks Lokbu Ýyw dks jksdus vkSj mldk bykt djus esa enn dj ldrs gSa- ikWyhiQsuksYl vkSj ÝysoksuksbM~l ls le`¼ tSrwu ds iRrs vkS"k/h; xq.kksa dk ,d vPNk lzksr gSa- bldkmi;ksx ,p1 ,u 1 ok;jl ls yM+us ds fy, fd;k tkuk pkfg,- ;g Lokbu Ýyw ds y{k.kksa dk bykt djus esa enn djrs gSa& tSls eryh] lnhZ] •k¡lh vkfn-

www.medicaldarpan.comiQkeZ 4 ?kks"k.kk i=k fu;e vkB nsf[k;s

1& izdk'ku LFkku& cqyUn'kgj 2& izdk'kufrfFk& ekfld 3 & eqnzd dk uke& czts'kdqekj xxZ] ukxfjdrk& Hkkjrh;] irk& dsúi-hú jksM] cqyUn'kgj 4& izdk'kd dk uke&czts'k dqekj xxZ] ukxfjdrk& Hkkjrh;] irk&dsúihú jksM] cqyUn'kgj 5& lEiknd dkuke& czts'k dqekj xxZ] ukxfjdrk&Hkkjrh;] irk& dsúihú jksM] cqyUn'kgj 6&mu O;fDr;ksa ds uke o irs tks lekpkj i=kds Lokeh gksa rFkk tks leLr iw¡th ds ,dizfr'kr ds lk>snkj ;k fgLlsnkj gksa& Jherhuh: xxZ] ukxfjdrk& Hkkjrh;] irk& dsúi-hú jksM] cqyUn'kgj- eSa czts'k dqekj xxZ,rn~ }kjk ?kksf"kr djrk gw¡ fd esjh vf/d`rtkudkjh ,oa fo'okl ds vuqlkj mQij fn;s x;sfooj.k lR; gSa&

&czts'k dqekj xxZ]izdk'kd-

O;Fkkru dk nnZ] pyk gh tkrk-eu dk nnZ] ;qxksa rd lrkrk-

u;k lkyle; ugha cnyk] lksp ugha cnyk-

vankt ugha cnyk] dsoy lky cnyk-

Mjftlls ftruk Mjksxs] og mruk gh Mjk,xk-ftlls ugha Mjksxs] og nwj Hkkx tk,xk-

vk'kkdHkh u dHkh] dgha u dgha-

liQyrk vk,xh] izxfr dks yk,xh-

rksanfcuk lksps] [kkrs tkuk-isV c<+kuk] jksx cukuk-

&MkWñ ujsUnz ukFk ykgk Xokfy;j (eñizñ)eksñ 09753698240-

D.O.B. NAME FIRM MOB. CITY STATE

24.03.72 SHRI AMIT JOSHI JI SWASTIK PHARMACLUTICALS 9826049524 INDOR MADHYA PRADESH

25.03.75 SHRI ARUN VERMA JI T.N.V. PHARMA 9359993814 ETWAH UTTAR PRADESH

26.03.73 SHRI AJAY JAIN JI ADBIO ORGANIES(P) LTD 9314044775 ALWAR RAJASTHAN

30.03.59 SHRI ANIL GHAI JI SIDHANT MEDICAL STORE 9760815213 DEHRADUN UTTRAKHAND

01.04.82 SHRI ABHISHEK VERMA JI VERMA MEDICAL STORE 8960178999 JAUNPUR UTTAR PRADESH

02.04.78 SHRI ANIL SEMWAL JI RONAK MEDICAL AGENCEY 9760613224 DEHRADUN UTTRAKHAND

03.04.84 SHRI ARVIND GOSWAMI JI DEEPAK MEDICAL STORE 9893116893 CHHATARPUR MADHYA PRADESH

05.04.85 SHRI ASHWIN JI ISCON PHARMA 9377674734 SURAT GUJARAT

05.04.97 SHRI ANSHUL AGARWAL JI ICR MEDICAL STORE 9713187809 MORENA MADHYA PRADESH

07.04.65 SHRI ANUJ GUPTA JI MANOJ MEDICOSE 9027881933 SAHARANPUR UTTAR PRADESH

08.04.75 ABRAR AHMED ANSARI JI KUMAR PHARMA 9425162983 JABALPUR MADHYA PRADESH

10.04.67 SHRI ARVIND SHARMA JI MISHRA MEDICAL STORE 9795177512 MAHOBA UTTAR PRADESH

22.04.80 SHRI AMIT KUMAR GUPTA JI ASHOK MEDICIN CENTER 9935971511 GORAKHPUR UTTAR PRADESH

23.04.70 SHRI AVINASH KUMAR SINGH JI JIDURG DISTIBUTORS 9431887149 MUNGER BIHAR

26.04.80 SHRI AVDESH KUMAR JI KUMAR MEDICAL STORE 9319023291 HARIDWAR UTTARAKHAND

26.04.86 SHRI ANSHUL LAKHOTIA JI UMA MEDICAL AGENCIES 9425286100 RAIPUR CHHATTISGARH

Spl Healthcare India Pvt. Ltd.SOAP:- ACNE CARE SOAP (TEA TREE OIL,JOJOBA OIL WALNUT LEAF EXTRACT,VITAMIN E& ALLANTOIN SOAP) l CLINTOP SOAP (KOIJ ACID,WALNUT LEAF EXT,KUIKUI NUT OIL,JOJO-BA OIL,TEA TREE OIL, & ALLANTOIN SOAP) l KESAR BABY SOAP (KESAR,VITAMIN E,ALOEVERA,ALMOND OIL & OLIVE OIL SOAP) l SCABINA GT SOAP (GAMMA BENZENE & CETRIM-IDE SOAP) l SCABINA PLUS SOAP (KETOCONAZOLE,CETRIMIDE & MENTHOL SOAP) lSCABINA SOAP (PERMETHRIN SOAP) l SEASONS SOAP (VITAMIN E,ALOEVERA,HONEY &GLYCERINE SOAP) l SPL NEEM SOAP (NEEM,TULSI,ALOE VERA & LEMON SOAP) l SULFSOAP (PRECIPITATED SULPHUR & SALICYLIC ACID SOAP) LIQUID ORAL (ALLOPATHIC):-AMBROZET LS SYRUP (AMBOXOL. GUIAPHENESIN & LEVOSALBUTAMOL SYRUP (30/50/1) lANACID MPS SUSPENSION (ALUMINIUM HYDROXIDE,MAGNESIUM HYDROXIDE & SIME-THICONE SUSPENSION (250,200,50) l AZIMET-100 SUSPENSION (AZITHROMYCIN 100MGSUSPENSION) l AZIMET-200 SUSPENSION (AZITHROMYCIN 200MG SUSPENSION) l

CETRAPHEN DS SUSPENSION (PARACETAMOL, CETIRIZINE & PHENYLEPHERINE SUSPEN-SION (250/2.5/5) l CLIMEX PLUS COUGH SYRUP (DEX-TROMETHORPHAN,PHENYLEPHERINE & CHLORPHENI-RAMINE MALEATE SYRUP (10,5,2) l COLDAMIN DROPS(PARACETAMOL,PHENYLEPHERINE & CPM DROPS) l

CYCLOMET PLUS SUSPENSION (DICYCLOMINE HCL. &PARACETAMOL SUSPENSION (5/125) l CYPROMA PLUSSYRUP (CYPROHEPTADINE WITH TRICHOLINE CITRATESYRUP) l CYPROMA PLUS SYRUP (WITH DROPPER) (CYPRO-HEPTADINE WITH TRICHOLINE CITRATE DROPS) l CYPROSILSYRUP (CYPROHEPTADINE 2MG.SYRUP) l DEXEPHEN PLUSSUSPENSION (PARACETAMOL, PHENYLEPHERINE & CHLOR-PHENIRAMINE MALEATE SYRUP (250,5,2) l MEFMET DS SUS-PENSION (MEFENAMIC ACID & PARACETAMOL (100/250) l

SPASFRESH AD DROPS (DICYCLOMINE HCL.& SIMETHICONEDROPS) l SPASMIN AD DROPS (DICYCLOMINE HCL.& SIME-THICONE DROPS) l SPDEX-15 COUGH SYRUP (DEX-TROMETHORPHAN,PHENYLEPHERINE & CHLORPHENI-RAMINE MALEATE SYRUP(15,5,2) l TIMS DMR COUGHSYRUP(BOX) (AMBROXOL,DEXTROMETHORPHAN, CETIRIZINE & MENTHOLSYRUP(15,10,5,0.5) l TIMS DMR COUGH SYRUP(NAKED) (AMBROXOL,DEXTROMETHOR-PHAN, CETIRIZINE & MENTHOL SYRUP(15,10,5,0.5) l ULTRACOLD DROPS (PARACETA-MOL,PHENYLEPHERINE & CHLORPHENIRAMINE MALEATE SUSPENSION (125,5,2) l ULTRA-COLD DS SUSPENSION (PARACETAMOL,PHENYLEPHERINE & CHLORPHENIRAMINEMALEATE SUSPENSION (125,5,2) l ULTRACOLD SUSPENSION (PARACETAMOL,PHENYLE-PHERINE & CHLORPHENIRAMINE MALEATE SUSPENSION (125,5,2) LIQUID ORAL(NUTRACEUTICAL):- ALLVIT DROPS (MULTIVITAMIN & MULTIMINERAL DROPS) l CALWELL-D3 DROPS (CHOLCALCIFEROL 400 IU DROPS(VITAMIN D3) l CINAFOL KIDS DROPS (FOLICACID,NIACINAMIDE & VITAMIN B12 DROPS) l FEFORANGE SYRUP (FERRIC AMMONIUM CIT-RATE,FOLIC ACID &VIT B12 SYRUP) l FERIWELL SYRUP (FERROUS ASCORBATE,FOLICACID & VITAMINS SYRUP) l HAEMO PLUS SYRUP (FERRIC AMMONIUM CITRATE,FOLICACID &VIT B12 SYRUP) l HB GROW XT SYRUP (FERROUS ASCORBATE,FOLIC ACID & VITA-MINS SYRUP) l HEMARON SYRUP (FERRIC AMMONIUMCITRATE,FOLIC ACID &VIT B12 SYRUP) l IROFER LDROPS (IRON WITH LYSINE DROPS) l METAGLOBINESYRUP (PROTEIN WITH IRON CONCENTRATE) l PAPEN-ZYME PLUS SYRUP (DIGESTIVE ENZYME WITH B-COM-PLEX VITAMINS SYRUP) l TONOPLEX SYRUP (VITAMIN BCOMPLEX WITH LYSINE SYRUP) l VITAORANGE SYRUP(FERRIC AMMONIUM CITRATE,FOLIC ACID &VIT B12SYRUP) l VITCOSPAN SYRUP (MULTIVITAMIN & MULTI-MINERAL SYRUP) EXTERNAL APPLICATIONS:- BIFOMETCREAM (BIFONAZOLE 1% CREAM) l CALOFEEL LOTION(CALAMINE,ZINC OXIDE,ALOEVERA EXT & LIGHT LIQUIDPARAFFIN) l CANDIMET-B LOTION (CLOTRIMAZOLEWITH BECLOMETHASONE LOTION) l CANDOZOLE EARDROPS (CLOTRIMAZOLE & LIGNOCAINE SOLUTION) lCANDOZOLE POWDER (CLOTRIMAZOLE 1% DUSTINGPOWDER) l FUNGICURE DROPS (CLOTRIMAZOLE & LIG-NOCAINE SOLUTION) l KETOGEN F OINTMENT (KETO-CONAZOLE,GENTAMICIN & FLUOCINOLONE ACETONIDE OINTMENT) l KETOMET SHAM-POO (KETOCONAZOLE 2% SHAMPOO) l KETOMET LOTION (KETOCONAZOLE 2% W/VLOTION) l KETOMET PLUS SHAMPOO (KETOCONAZOLE WITH ZPTO SHAMPOO) l LULIMETCREAM (LULICONAZOLE 1% CREAM) l LULIMET LOTION (LULICONAZOLE LOTION 1% W/V)l SCABINA LOTION (GAMMA BENZENE & CETRIMIDE LOTION) l SENSOCOOL MOUTHWASH(CHLORHEXIDINE GLUCONATE MOUTHWASH) l SILVEX PLUS CREAM (SILVER NITRATE &CHLORHEXIDINE GLUCONATE CREAM) l SILVEX PLUS CREAM (SILVERSULPHADIAZINE,CHLORHEXIDINE GLUCONATE,ALLANTOIN WITH ALOES CREAM) l

TRISORE BUCCAL PASTE (TRIAMCINOLONE ACETONIDE BUCCAL PASTE) l ULTRASCABLOTION (GAMMA BENZENE & CETRIMIDE LOTION) VOLIFLAM GEL (DICLOFENAC,MEN-THOL,METHYL SALICYLATE GEL) TABLETS & CAPSULES (AYURVEDIC):- EMP FORTETABLET (AYURVEDIC GYNAEC TABLET) l GYNA CARE CAPSULE (AYURVEDIC GYNAECCAPSULES) l MENSTROZAK FORTE CAPSULE (AYURVEDIC GYNAEC CAPSULES) TABLETS& CAPSULES:- AZIMET 250 TABLET (AZITHROMYCIN TABLET 250MG) l AZIMET 500 TABLET(AZITHROMYCIN TABLET 500MG) l CETRAPHEN DS TABLET (PARACETAMOL,PHENYLE-PHERINE, CETIRIZINE TAB(500,5,5) l D-MET MR TABLET (DICLOFENAC POTTASIUM,PARAC-ETAMOL & CHLORZOXAZONE TABLET) l ERGOT FORTE TABLET (PREPARED ERGOTTABLET) l EVAMET-400 CAPSULE (VITAMIN E CAPSULE 400 I.U.) l ULTRAMOX 250 CAP-SULE (AMOXYCILLIN 250MG CAPSULE) l ULTRANAC SP TABLET (ACECLOFENAC,PARAC-ETAMOL & SERRATIOPEPTIDASE TABLET) AYURVEDIC PREPARATIONS:- BABY NZYMEDROPS (AYURVEDIC CARMINATIVE DROPS) FOOT CREAM (FOR FOOT CRACKS & CAL-LOUSES) l KESH KALP HAIR OIL (AYURVEDIC HAIR OIL) l NAUTROL HAIR OIL (AYURVEDIC

HAIR OIL) l SANDHI SATHI OIL (AYURVEDIC PAIN RELIEVING OIL) l SPL GOLD DROPS(SUVARNA PRASHAN DROPS) l SPL GOLD NONI (AYURVEDIC FAMILY HEALTH TONIC) l SPLRELEEF OIL (ROLL ON BOTTLE) (AYURVEDIC PAIN RELIEVING OIL) MISCELLANEOUSPRODUCT:- CALWELL D3 SACHET (CHOLCALCIFEROL SACHET60,000 I.U.) l ARGIFEELSACHET (L-ARGININE,FOLIC ACID,PROANTHOCYANIDINE,CYANOCOBALAMINE & PYRIDOX-INE SACHETS) l DENTOMET GUM PAINT (CETIRIMIDE, TANNIC ACID, CHOLINE SALICYLATE& LIGNOCAINE GUM PAINT) l FLORAC-Z SACHET (PROBIOTIC POWDER WITH COLOSTRUM& ZINC) l IROFEEL SACHET (FERROUS FUMARATE,FOLIC ACID & VITAMIN C SACHET) lJOINT FIT POWDER (GLUCOSAMINE,VITAMINS & ANTIOXIDANTS) l LACTOCID-B SACHET(LACTOBACILLUS SPOROGENES SACHET) l LYPOBION INJECTION (B COMPLEX& VIT.12MULTIDOSE VIAL) l VITACHARGE Z POWDER (KACHA AAM) (ENERGY DRINK POWDER) lVITACHARGE Z POWDER (LEMON) (ENERGY DRINK POWDER) l VITACHARGE Z POWDER(ORANGE) (ENERGY DRINK POWDER) l VITACHARGE Z POWDER (ORANGE) (ENERGYDRINK POWDER) VETERINARY PRODUCTS:- CALCIMORE GOLD (LIQUID SUPPLEMENT OFCALCIUM, PHOSPHOROUS,VITAMIND3,H & B12) l GLENCAL GOLD GEL (LIQUID SUPPLE-

MENT OF CALCIUM, PHOSPHOROUS,VITAMIND3, H & B12 lSPL SHAKTI GOLD GEL (LIQUID SUPPLEMENT OF CALCIUM,PHOSPHOROUS, VITAMIND3, H & B12) l SUPERCAL GOLDGEL (LIQUID SUPPLEMENT OF CALCIUM, PHOSPHOROUS,VITAMIND3,H & B12) l SUPERMILK GOLD GEL (LIQUID SUP-PLEMENT OF CALCIUM, PHOSPHOROUS, VITAMIND3, H & B12)l R K GOLD CALCIUM GEL (LIQUID SUPPLEMENT OF CALCI-UM, PHOSPHOROUS, VITAMIND3, H & B12) l SPL GROWMINFORTE POWDER (CHELATED MINERAL MIXTURE FOR HIGHLACTATION AND NUTRITION.) l VITABOOST LIQUID (GLUCO-NEOGENIC PRECURSORS FORTIFIED WITH B-COMPLEX VITA-MINS) l SPL LIVMIN VET (LIVER TONIC FORTIFIED WITHYEAST EXTRACT) l MASTIFIX POWDER (POWDER FOR MAS-TITIS TREATMENT)

Mob.:- +91 9979791155MAIL : spl_india_1987@hotmail.com WEBSITE : www.splhealthcare.com

Suprima A Division Of INTASZoryi-M1 (Glimepirde 1 mg + Metformin Hydrochloride (ER) 500 mg Tablets) l Zoryl-M2(Glimepirde 2mg + Metforimin Hydrochloride (ER) 500 mg Tablets) l Zoryl-M3 (Glimepirde 3 mg+ Metformin Hydrochloride (ER) 500 mg Tablets) l Zoryl-M4 (Glimepirde 4 mg + MetforminHydrochloride (ER) mg Tablets) l Zoryl-M0.5 (Glimepirde 0.5 mg n+ Metformin Hydrochloride (ER)500 mg Tablets) l Zoryl-MV1 (Glimepiride 1 mg Voglibose 0.2mg + Metformin Hydrochloride 500mg (SR) Tablets) l Zoryi-MV2 (Glimepiride 2mg + Voglibose 0.2mg + Metformin Hydrochloride 500mg (SR) Tablets) l Zoryl-MC1/0.3 (Glimepiride 1 mg + Voglibose 0.3 mg + Hydrochloridr 500 mg(SR) Tablets) l Zoryl-MV2/0.3 (Glimepiride 2mg + Voglibose 0.3 mg + Metformin MeetforminHydrochloride 500 mg (SR) Tablets) l Arvast-5 (Rosuvastatin Calcium 5 mg Tablet) l Arvast-10(Rosuvastatiin Calcium 10 mg Tablet) Arvast-15 (rosuvastatin Calcium 15 mg Tablet) Arvast-20(Rosuvastatin Calcium 20mg Tablet) l Arvast-30 (Rosuvastain Calciumj 30 mg Tablet) l Arvast-40 (Rosuvastatin Calcium 40 mg Tablet) l Arvast-CF5/10 (Rosuvastation Calcium 5/10 mg +

Choline Fenofibrate 135 mg Capsule) l Arvast CV 10(Rosuvastation Calcum 101 mg + Clopidogrel 75 mg Capsule)l Arvast-A (Rosuvastation Calcium 10 mg + Aspirin 75 mg/150 mg Capsule) Adilip 45/135 (Choline Feknofibrate (Eq. toFenoflbric acid) 45 /135mg DR Tablet)

Mob:- 09927857406, 09450294951.

AlembicGlisen (Micronized Glimepiride 1/2 mg) l Glisen MF Forte

(Glimepiride 1mg /2mg + Metformin sustained release 1000Mg) l Gliusen MF (Glimepride 1/2mg Metformin 500 mg SR+ Voglibose 0.2/0.3mg) l Glisen PM (Glimepiride 1/2 mg +Piogliitazone 15 mg + Metformin M Teneligliptinj 20 mg + met-formin SR 500/1000 mg) l Tellzy-Ch 40/80 (Telmisartan 20mg / 40mg / 80mg) l Tellzy MT (Telmisartan 40 mg +Metoporolol Extended Release 25/50 mg) l Tellzy-AM

(Telmisartan 40/80 mg + Amlodipine 5mg) l Tellzy-H 40/80

(Telmisartan 40/80 mg + HCTZ 12.5 mg) l Tellzy-AH

(Telmissartan 40 mg + Amlodipine 5 mg + HCTZ12.5 mg) l Tellzy-RS (Telmisartan 40 mg +RTosuvastatin 10 mg) l Synx (RenolazineExtended Release Tablets 500mg) l Duba Tran

(Dabigatran 75mg/110mg/150mg) Ph.:- 91-22-30611666.

Torrent PharmaChymoral Forte (Typsin: Chymotrysin (6:1)1,00,000 A.U) l Presmovac (Prcalopride 1/2mg Tablets) l Norpregalin (Nortriptyline 10mg+ Pregablin 75 mg tablets) l True Ceprol OD(Oxaceprol 600 mg SR Tablets) l Pregalin X(Pregabalin Sustained Release 75 mg +Methycobalamin 1500 mg Tablets) l I-VIT 12-Ing.(High dose Vitamin B12 :2500 mcg +Folic:acid : 0.7 mg + Niacinamide : 12mg & Vitamin C: 150 mg) l Febugood l 40/80 (Fexuxostat40/80 tab) l Hqtor (Hydroxychloroquine Sulfate200/400 mg Tablets)

Mob:- 09336277068, 09985232504,09927041480.

Product List

Happy Birthday

eSMhdy niZ.k ehfM;k gkÅl dh rjiQ ls vki lHkh dks tUefnu dh gkfnZd 'kqHkdkeuk;sa

ekpZ o vizSy ekg ds R;kSgkj20-03-2019 pkSeklh pkSnl] NksVh gksyh] gksfydk

ngu] iwf.kZek miokl21-03-2019 gksyh] olUr iwf.kZek] nksy iwf.kZek]v"Vkfgdk fo/ku iw.kZ] iQkYxqu iwf.kZek] y{eh t;urh]pSrU; egkizHkq t;Urh] olUr lEikr] iSUxquh mfFkje

22-03-2019 pS=k izkjEHk] HkkbZ nwt] Hkkr` f}rh;k] xqMizQkbMs

23-03-2019 f'kokth t;Urh24-03-2019 lad"Vh prqFkhZ] bZLVj25-03-2019 jax iapeh27-03-2019 'khryk lIreh28-03-2019 clksM+k] 'khryk v"Veh] dkyk"Veh] o"khZ

ri vkjEHk31-03-2019 ikieksfpuh ,dkn'kh01-04-2019 oS".ko ikieksfpuh'kh] cSad vodk'k02-04-2019 iznks"k ozr03-04-2019 ekfld f'kojkf=k04-04-2019 n'kZ vekoL;k05-04-2019 pS=k vekoL;k06-04-2019 pUnz n'kZu] pS=k f'kojkf=k] xqMh iM+ok]

;qxknh07-04-2019 >wysyky t;Urh08-04-2019 xkSjhiwtk] x.kxkSj] eRl; t;Urh]

ekfld dkfrZxkbZ09-04-2019 fouk;d prqFkhZ] y{eh iapeh10-04-2019 LdUn "k"Bh] jksfg.kh ozr11-042019 ;equk NB12-042019 uoin vksyh izkjEHk13-04-2019 ekfld nqxkZ"Veh] jkeuoeh] LekrZ]

egkrkjk t;Urh14-04-2019 jke uoeh] oS".ko] lksyj uoo"kZ] es"k

laØkfUr] cSlk[kh] iqFkUMw] vEcsMdj t;Urh15-04-2019 dkenk ,dkn'kh] fo"kq dkuh] igsyk

oS'kk[k16-04-2019 xkS.k dkenk ,dkn'kh] oS".ko dkenk

,dkn'kh] okeu }kn'kh17-04-2019 iznks"k ozr] egkohj Lokeh t;Urh19-04-2019 guqeku t;Urh] pS=k iwf.kZek] iwf.kZEkk

miokl] uoin vksyh iw.kZ] fp=kk iw.kZukeh20-04-2019 oS'kk[k izkjEHk

AB ALL CAREALBENDAZOLE IP 400MG, ALBENDAZOLE IP 400MG ,IVER-MECTIN IP 6MG ,EXCIPIENTS : Q.S, FLUCONAZOLE IP 150MG EXCIPIENTS : COLOUR: PONCEAU 4R, ACECLOFENACIP 100MG,PARACETAMOL IP 325 MG, ACECLOFENAC IP100MG,PARACETAMOL IP 325 MG, ACECLOFENAC IP 100MG, PARACETAMOL IP 325 MG ,SERRATIOPEPTIDASE USP15MG, Aceclofenac IP 100MG ,Thiocolchicoside IP 4M : ACE-CLOFENAC IP 100 MG , PARACETAMOL IP 325 MG ,CHLOR-ZOXAZONE USP 250 MG, CEFIXIME TRIHYDRATE IP 100MG,CEFIXIME TRIHYDRATE IP 200 MG, CEFIXIME 200MG + LAC-TIC ACID BACILLUS 2.5 BSP, CEFPODOXIME PROXETIL IP100 MG, CEFPODOXIME PROXETIL IP 200MG, CEFIXIME200MG, OFLOXACIN IP 200MG, AZITHROMYCIN IP 250MG.AZITHROMYCIN IP 500MG, DROTAVERINE HYDROCHLO-RIDE 80 MG EQ. TO DROTAVERINE EXCIPIENTS COLOUR:APPROVED COLOUR TO BE USED, METHYLCOBALAMIN500 MCG GABAPENTIN USP 300 MG, METHYLPREDIS-OLONE IP 4MG, METHYLPREDISOLONE IP 8MG, FER-ROUS ASCORBATE 100 MG EQ. TO ELEMENTAL IRONFOLIC ACID IP 1.5 MG EXCIPIENTS : COLOUR: PONCEAU4R, ERYTHROSINE LAKE & TITANIUM DIOXIDE IP, DEFLAZA-CORT 6 MG, OFLOXACIN IP 200MG, EXCIPIENTS;COLOUR :TITANIUM DIOXIDE IP, OFLOXACIN IP 200 MGORNIDAZOLE IP 500MG, CALCIUM CARBONATE IP 1250 MG,FROM ORGANIC SOURCE 9 OYSTER SHELL) EQ. TO ELE-MENTAL CALCIUM 500MG VITAMIN D3 IP 250 IU EXCIPI-ENTS: COLOUR ; TITANIUM DIOXIDE IP, TRANEXMIC ACIDIP 250MG ,ETAMSYLATE BP 250MG, PANTOPRAZOLE SODI-UM SESQUIHYDRATE IP 40MG, PANTOPRAZOLE SODIUMSESQUIHYDRATE IP 40MG EQ. TO PANTOPRAZOLE DOM-PERIDONE IP 10MG, LEVOCETIRIZINE DIHYDROCHLORIDEIP 5MG MONTELUKAST SODIUM IP 10MG, PARACETAMOLIP 650 MG, NIMUSLIDE 100MG + PARACETAMOL 325MG,TRAMADOL HYDROCHLORIDE IP 50MG PARACETAMOL IP325 MG, AMOXYCILLIN 500MG , POTASSIUM CLAVUNATEACID 125MG, DICLOFENAC SODIUM IP 50MG PARACETA-MOL IP 325 MG MAGNESIUM TRISILICATE IP 100MG,EXCIPIENTS : ONDANSETRON HYDROCHLORIDE IP 4MG,LEVOFLOXACIN HEMIHYDRATE IP 500 MG, LORNOXACAM8MG + PRACETAMOL 325MG, ATORVASTATIN CALCIUM 10MG, ATORVASTATIN CALCIUM IP 20 MG EQ. TO ATORVAS-TATIN EXCIPIENTS : COLOUR: APPROVED COLOUR TO BEUSED, RABEPRAZOLE SODIUM IP 20MG EXCIPIENTS:COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDEIP, RABEPRAZOLE SODIUM IP 20MG DOMPERIDONEIP 10MG, ESOMEPRAZOLE MAGNESIUM TRIHYDRATEIP 40 MG EQ. TO ESOMEPRAZOLE MAGNESIUMEXCIPIENTS: COLOUR: APPROVED COLOUR TO BEUSED, CINNARIZINE IP 20 MG, DOMPERIDONE IP 15MG EXCIPIENTS, URSODEOXYCHOLIC ACID IP300MG, TERBINAFINE 250MG, LEVOCETRIZINE 5MG,CEFIXIME 200MG + AZITHROMYCIN 250 MG, NIME-SULIDE 100MG , PARACETAMOL 325 MG,PHENYEPHRINE HYDROCHLORIDE 5MG, CETRIZINE5MG, CAFFEINE 25MG, TELMIALL 40MG, CAPSULESGROUP:- PANTOPRAZOLE SODIUM SESQUIHYDRATEDOMPERIDONE 30MG, RABERPRAZOLE SODIUM20MG , DOMPERIDONE IP 30MG, RABEPRAZOLE SODI-UM 20 MG ) LEVOSULPIRIDE 75 MG, OMEPRAZOLE IP2OMG, OMEPRAZOLE IP 20MG (AS ENTERIC COATEDPELLETS) DOMPERIDONE IP 10MG (AS GRANULES),LYCOPENE 10% 10,000 MCG , BETACAROTONEBETACAROTONE 10MG, GREEN TEA EXTRACT 125MG,ZINC SULPHATE MONOHYDRATE 27.45MG, SODICUM SELE-NATE 100MCG , VITAMIN C 25 I.U , VITAMIN C 50MG VITAMINA 5000 I.U, AMOxicillin trihydrate 500mg capsules, Amoxicillin250 mg, Dicloxacillin 250 mg, itraconazole 100 mg capsule,SOFT GEL CAPSULES:- CALCITRIOL BP 0.25 MCG, CALCIUMCITRATE USP 425 MG, + ZINC SULPHATE + MONOHYDRATEUSP 20 MG , MAGNESIUM OXIDE IP 40 MG EXPIPIENTES Q.SSOFTGEL CAP, CALCIUM CARBONATE IP 625 MG , CAL-CITROL IP 0.25 MCG, VITAMIN K27 MCG.

Mob.:- 08847202205, 09805027042.

Pharma Roots HealthcareTABLETS (NON-BETALACTAM) (DEFLAZACORT 6MG - RS67/- TO RS 95/- (10 X 10 ALU ALU PACKING), (CETRIZINE10MG TABLET - RS 47/- TO RS 65 (50 X 10 BLISTER PACK-ING), (ACCECLOFENAC 100MG + PARACETAMOL 325MG +THIOCHOLCHIKOSIDE 4MG: RS 310/- TO RS 380/- (10 X 1 X10 ALU ALU PACK) l TABLETS (BETALACTAM) (AMOXY-

CILLIN 500MG + CLAVLANIC ACID 125MG - RS 249/- TO RS294/- (1X6X10 ALU ALU PACK), (CEFPODOXIME 200MG +CLAVLANIC ACID 125MG - RS 335/- TO RS 390/- (1X6 X10 ALUALU PACK), (CEFIXIME 200MG + OFLOXACIN 200MG - RS310/- TO RS 365/- (10 X 10 ALU ALU PACK) l CAPSULES(RABIPRAZOLE 20MG + DOMPERIDOME 30MG SR CAP-SULES - RS 63/- TO RS 78/- (10 X 10 ALU ALU PACK),(RABIPRAZOLE 20MG + LEVOSULPRIDE 75 CAPSULES - RS130/- TO RS 170/- (10 X 10 ALU ALU PACK), (PANTOPARA-ZOLE 40MG + DOMPERIDOME 30MG SR CAPSULES - RS 88/-TO RS 108/- (10 X 10 ALU ALU PACK) l LIQUID (LACTULOSE100ML - RS 25/- TO RS 35/- WITH CARTON), (LACTULOSE200ML - RS 48/- TO RS 68/- WITH CARTON) l DRY INJEC-TIONS (PANTOPARAZOLE 40MG - RS 6.90/- TO RS 8.50/-

WITH CARTON AND SODIUM CARBONATE) l SOFT GEL(VITAMIN D3 CAPSULE RS 85/- TO RS 110/- (1X4X10 BLISTERPACK. PH.:- 88472-48892, 62395-40054, 88377-83433.

Greenleaf FormulationTablets:- CHOLEAF-60K (HOLECALCIFEROL-60000 I.UCHEWABLE TABLET IN ORANGE FLAVOUR) l LEAFCID

JUNIOR 15 (LENSOPRAZOLE 15MG DISPERSIBLE TABLETS

IN ORANGE FLAVOUR) l LEAF-CID JUNIOR 30 (LENSOPRA-ZOLE 30MG DISPERSIBLE TABLETS IN ORANGE FLAVOUR)l LEAFCIN-200 (OFLOXACIN 200MG) l LEAFCIN-OZ

(OFLOXACIN 200MG, ORNIDAZOLE 500MG) l GRECEFF-100

(CEFIXIME 100MG DISPERSIBLE TABLETS) l GRECEFF-200

(CEFIXIME 200 MG DT,LACTOBACILLUS 250 MILLIONSPORES DISPERSIBLE TABLETS) l GRECEFF-OF

(CEFIXIME 200MG,OFLOXACIN 200MG) l GRECEFF-AZ 250

(CEFIXIME 200MG,AZITHROMYCIN 250MG) l GRECEFF-OZ

(CEFIXIME 200MG,ORNIDAZOLE 500MG) l GRECEFF-CV

(CEFIXIME 200MG, CLAVULANIC ACID 125MG) l CEF-

POLEAF-100 (CEFPODOXIME PROXETIL 100MG DIS-

PERSIBLE TABLETS) l CEFPOLEAF-200 (CEFPODOXIMEPROXETIL 200MG DISPERSIBLE TABLETS) l CEFPOLEAF-

CV (CEFPODOXIME PROXETIL 200MG, CLAVULANIC ACID125MG) l CEFPOLEAF-OF (CEFPODOXIME PROXETIL

200MG, OFLOXACIN 200MG) l CEFPOLEAF-AZ (CEFPO-DOXIME PROXETIL 200MG, AZITHROMYCIN 250MG) l LEAF-

CLAV-625 (AMOXYCILLIN 500MG,CLAVULANIC ACID 125MG)l LEAFCLAV-375 (AMOXYCILLIN 250MG, CLAVULANIC ACID125MG) l LEAFZOLID-600 (LINEZOLID 600MG) l FAROLEAF

(FAROPENAM SODIUM EXTENDED RELEASE 200MG) l SLT-

375 (SULTAMICILLIN 375MG) l AZROLEAF-250

(AZITHROMYCIN 250MG) l AZROLEAF-500 (AZITHROMYCIN500MG) l LEVOFLAZ-500 (LEVOFLOXACIN 500MG) lGREXIME-250 (CEFUROXIME AXETIL 250MG) l GREXIME-

500 (CEFUROXIME AXETIL 500MG) l LEAFNIM-MD (NIME-SULIDE 100MG MOUTH DISSOLVING TABLET IN ORANGE

FLAVOUR) l LEAFNIM-SPAS (NIMESULIDE 100MG, DICY-CLOMINE HCL 10MG) l LEAFNIM-P (NIMESULIDE 100 MG,PARACETAMOL 325 MG) l PAINLEAF-SPAS (DICYCLOMINEHCL 20MG, PARACETAMOL 325MG) l PAINLEAF-650

(PARACETAMOL 650MG DISPERSIBLE TABLETS) l

PAINLEAF-1000SR (PARACETAMOL 1000MG SUSTAINED

RELEASE) l LEAFCAM-20 (PIROXICAM 20MG DISPERSIBLE

TABLETS) l LEAFLAM-PLUS (ACECLOFENAC 100MG, THIO-COLCHICOSIDE 4MG) l LEAFLAM-TH (ACECLOFENAC100MG, PARACETAMOL 325MG, THIOCOLCHICOSIDE 4MG) lLEAFLAM-P (ACECLOFENAC 100MG, PARACETAMOL 325MGDISPERSIBLE TABLETS) l LEAFLAM-SP (ACECLOFENAC100MG, PARACETAMOL 325MG, SERRATIOPEPTIDASE15MG) l LEAFLAM-MR (ACECLOFENAC 100MG, PARACETA-MOL 325MG, CHLORZOXAZONE 250MG) l FINELEAF-P

(DICLOFENAC POTASSIUM 50MG, PARACETAMOL 325MG) lFINELEAF-SP (DICLOFENAC POTASSIUM 50MG, PARACETA-MOL 325MG, SERRATIOPEPTIDASE 10MG) l FINELEAF-MR

(DICLOFENAC POTASSIUM 50MG, PARACETAMOL 325MG,CHLORZOXAZONE 250MG) l LEAFDOL-P (TRAMADOL37.5MG, PARACETAMOL 325MG) l FINELEAF-SPAS (ACE-CLOFENAC 100MG, DROTAVERINE 80MG) l XIBOTOR-90

(ETORICOXIB 90MG TABLET COLOUR ORANGE) l

XIBOTOR-120 (ETORICOXIB 120MG TABLET COLOUR

MAGENTA) l XIBOTOR-PLUS (ETORICOXIB 60MG, PARAC-ETAMOL 325MG) l XIBOTOR-TH (ETORICOXIB 60MG, THIO-COLCHICOSIDE 4MG) l GROWSHINE (GROW-AMINO ACID,BIOTIN, CALCIUM PANTOTHENATE, MULTIVITAMINS, MULTI-MINERALS) l GREACORT-6 (DEFLAZACORT 6MG) lISOLEAF-40 (SR) (ISOXSUPRINE 40MG SUSTAINED

RELEASE) l TRYMILIN-PLUS (TRYPSIN 48MG, BROMELAIN90MG, RUTOSIDE TRIHYDRATE 100MG, DICLOFENAC 50MG)l LEAFJOINT (DIACERIN 50MG, MSM 250, GLUCOSAMINE750MG) l GRESPAS-MF (DROTAVERINE 80MG, MEFENAMIC

ACID 250MG) l VOMNICE-MD 4 (ONDANSETRON HCL 4MGMOUTH DISSOLVING TABLET IN ORANGE FLAVOUR) lFULANGIL-150 (FLUCONAZOLE 150MG) l FABITAST-40

(FEBUXOSTAT 40MG) l THYROLEAF-25 (THYROXINE SODI-UM 25MCG) l THYROLEAF-50 (THYROXINE SODIUM50MCG) l THYROLEAF-100 (THYROXINE SODIUM 100MCG)l ZINTOLEAF-COLD (PARACETAMOL 325MG, LEVOCETI-RIZINE 2.5MG, PHENYLEPHRINE 10MG, CAFFEINE 30MG) lLEAFNIM-CC (NIMESULIDE 100MG, PARACETAMOL 325MG,PHENYLEPHRINE HCL 10MG, CETIRIZINE HCL 5MG, CAF-FEINE 25MG) l ZINTOLEAF (LEVOCETIRIZINE 5MG) l ZIN-

TOLEAF-M KID (LEVOCETIRIZINE 2.5MG, MONTELUKAST4MG) l ZINTOLEAF-M (LEVOCETIRIZINE 5MG, MON-TELUKAST 10MG BILAYERED TABLET) l ZINTOLEAF-AM

(LEVOCETIRIZINE 5MG, AMBROXOL 60MG) l ZINTOLEAF-

PLUS (LEVOCETIRIZINE 5MG, MONTELUKAST 10MG, ACE-BROPHYLLINE 200MG (SR) l ZINTOLEAF-FORTE (LEVOCE-TIRIZINE 5MG, MONTELUKAST 10MG, AMBROXOL 75MG) lFEXOGREN-M (FEXOFANADINE120MG,MONTELUKAST10MG BILAYERED TABLET) l LINHISTIN-16 (BETAHISTINE16MG) l PREGALEAF-SR (PREGABALIN 75MG SUSTAINED

RELEASE), METHYLCOBALAMIN 1500MCG) l LEAFCOB-NT

(PREGABALIN 75MG, NORTRIPTYLINE10MG) l LEAFCOB-

ALA (MECOBALAMIN 1500MCG, ALPHA LOPIC ACID 100MG,FOLIC ACID 1.5MG, PYRIDOXINE 3MG, THIAMINE 10MG) lLEAFCOB-MNT (PREGABALIN 75MG, METHYLCOBALAMIN1500MCG, NORTRIPTYLINE10MG) l LEAFPRIN-40SR (ISOX-SUPRINE 40MG(SR) l PLEAF-40 (PANTOPRAZOLE 40MG) lPLEAF-D (PANTOPRAZOLE 40MG, DOMPERIDONE 10MG)RABLEAF-20 (RABEPAZOLE 20MG) l RABLEAF-D (RABEPA-ZOLE 20MG, DOMPERIDONE 10MG) Mob.:- +91 9317777888.

CISTA MEDICORPANTIBIOTICS & ANTIBACTERIALS:- Amroxil 250 Capsule(Amoxycillin 250 mg) l Amroxil 500 Capsule (Amoxycillin 500mg) l Amroxil CV 375 Tablet (Amoxycillin 250mg + Clavulanic125mg) l Amroxil CV 625 Tablet (Amoxycillin 500mg +Clavulanic 125mg) l Amroxil CV 625 LB Tablet (Amoxycillin500mg + Clavulanic 125mg LB) l Amroxil CV Dry Syrup(Amoxycillin 200mg + Clavulanic 28.50mg) l Amroxil CV (WFI)Dry Syrup (Amoxycillin 200mg + Clavulanic 28.50mg with Water)

l Amroxil CV 457 Dry Syrup (Amoxycillin 400 mg +Clavulanic 57mg with Water) l Amroxil D Tablet(Amoxycillin 250 mg + Dicloxacillin 250 mg Lactid AcidBacillus 2.5 Million Spores) l Azipril 250 Tablet(Azithromycin 250 mg) l Azipril 500 Tablet (Azithromycin500 mg) l Azipril 100 Suspension (Azithromycin 100 mgper 5 ml) l Azipril 200 Suspension (Azithromycin 200 mgper 5 ml) l Fixip 100 Tablet (Cefixime 100mg) l Fixip 200LB Tablet (Cefixime 200mg (Lactic Acid Bacillus) l FixipDS LB Dry Syrup (Cefixime 50mg/5ml With water) l FixipO Tablet (Cefixime 200mg + Ofloxacin 200mg Lactic AcidBacilus) l Fixip O DS Dry Syrup (Cefixime 50mg +Ofloxacin 50mg per 5ml) l Fixip CV Tablet (Cefixime200mg + Clavulanic Acid 125mg) l Fixip CV DS Dry Syrup(Cefixime 200mg + Clavulanic Acid 28.50mg) l Imipod 100Tablet (Cefpodoxime Proxetil 100mg) l imipod 200 Tablet(Cefpodoxime Proxetil 200mg) l Imipod 50 Dry Syrup(Cefpodoxime 50mg with Water) l Imipod 100 Dry Syrup(Cefpodoxime 100mg with Water) l Imipod CV 325 Tablet(Cefpodoxime 200mg + Clavulanic Acid 125mg) l ImipodCV 225 Tablet (Cefpodoxime 100mg + Clavulanic Acid

125mg) l Imipod CV DS Dry Syrup (Cefpodoxime 50 mg +Clavulanic Acid 28.50mg With Water) l Imipod CV DS EXTRADry Syrup (Cefpodoxime 100 mg + Clavulanic Acid 28.50mg with

Water) l Imipod O (LB) Tablet (Cefpodoxime 200mg +Ofloxacin 200mg Lactic Acid Bacilus) l Futex 250 Tablet(Cefuroxime Axetil 250mg) l Futex 500 Tablet (CefuroximeAxetil 500mg) l Futex CV Tablet (Cefuroxime 500 mg +Clavulanic Acid 125 mg) l Elquix 500 Tablet (Levofloxacin500mg) l Elquix 750 Tablet (Levofloxacin 750mg) l Elquix OZTablet (Levofloxacin 250mg + Ornidazole 500 mg) l VoxlinTablet (Linezolid 600 mg) l Aclina 300 Capsule (Clindamycin300mg) l Flovix 200 Tablet (Ofloxacin 200mg) l Flovix 300Tablet (Ofloxacin 300mg) l Flovix OZ Tablet (Ofloxacin 200mg+ Ornidazole 500mg) l Flovix OZ (Half) Tablet (Ofloxacin100mg + Ornidazole 250mg) l Movilox Tablet (Moxifloxacin400mg) l Movilox CF SR Tablet (Moxifloxacin 400mg SR +Cefixime 400mg SR) l Claroff 250 Tablet (Clarithromycin 250mg) INJECTABLES:- Ceftrial 250 Dry Injection (Ceftriaxone250mg) l Ceftrial 500 Dry Injection (Ceftriaxone 500mg) lCeftrial 1000 Dry Injection (Ceftriaxone 1000mg) l Ceftrial SB375 Dry Injection (Ceftriaxone 250mg + Sulbactam 125mg) lXymor Dry Injection (Ceftriaxone 1gm + Sulbactum 500mg) lCeftrial TZ 1.125 Dry Injection (Ceftriaxone 1gm + Tazobactum125mg) l Celzon SB 1.0 Dry Injection (Cefoperazone 500mg +Sulbactam 500mg) l Celzon SB 1.5 Dry Injection(Cefoperazone 1gm + Sulbactam 500mg) l Cistaz 1000 DryInjection (Ceftazidime 1gm) l Ractum 4.5 Dry Injection(Piperacillin 4gm and Tazobactum 500mg Inj) l Aclina 600 InjLiquid Injection (Clindamycin 600mg) l Mervin Dry Injection(Meropenem 1gm) l Dupanta 40 Dry Injection (Pantoprazole40mg Inj) l Esodrip 40 Dry Injection (Esomeprazole 40mg Inj)

Mob.:- 07508340032.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds tks fd iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj ds uke ls gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsa-

Product List

March 20-21, 2019 Optics 2019 Singapore. The 2ndInternational Conference on Lasers and Optics and Photonicswill be held in Singapore City and discuss the most recentprogressions in the field of Optics, Photonics, and Lasers. Fordetails Contact: Meetings International Pte Ltd., 28, MaxwellRoad, 03-05 Red Dot Traffic, Singapore 069120. Tel.: +800-

852-6126 and/or +65-31080483. E-Mail: contact@ meet-

ingsint.com ; Website: https://

www.meetingsint.com/conferences/ optics

March 21-22, 2019 Human Metabolism 2019 Dubai,

U.A.E. The 25th International Conference on HumanMetabolism Health Diabetes , Obesity & Metabolism isscheduled during March 21-22, 2019 in Dubai, U.A.E.with theme of Collective impact on Human Metabolism.Human Metabolic Health - Diabetes, Obesity &Metabolism organizes a scientific gatherings with theneed of bringing together world renowned researchersand scientists to ponder upon the challenges and solu-tions faced by the social community. For detailsContact: Jack Jones, Program Manager, HumanMetabolism 2019, 47 Church field Road, London, W36AY, U.K. Tel.: +44-2088190774. E-mail: jack-

j o n e s 5 5 4 5 5 @ g m a i l . c o m

humanmetabolism2019@gmail.com Website :

https://humanmetabolism. healthconferences.org

March 21-22, 2019 ICAMR 2019 Dubai, U.A.E. InternationalConference on Antimicrobial Resistance (ICAMR) will be heldat Le Meridien Dubai Hotel & Conference Centre, Dubai,UAE. For details Contact: Conference Secretariat, Info PlusEvents LLC, Suite 1406, Lake Central Tower, Al Abraj Street,Burj Khalifa Community, P.O. Box: 71108, Dubai, UAE. Tel.:

+971-4-4218996. E Mail: Plus@infoPlusEvents.com

Website: www.infoplusevents.com and/or www.icamr-

uae.com

March 21-23, 2019 Neonatal Pediatrics Conference

2019 Dubai, U.A.E. 28th World Neonatal, Pediatricsand Family medicine conference will be held in Dubai,U.A.E. For details contact: Jane Grey, ProgramManager, Faneotrics 2019, 47, Churchfield Road,London, W3 6AY, U.K. Tel.: +1-201-380-5561, Toll Free

No: +44-2088190774. Email:

faneotrics2019@gmail.com, Website:

https://www.neonatal. pediatricsconferences.com

March 21-23, 2019 Indo Health Care 2019 Jakarta,

Indonesia. The 11th edition of Indo Healthcare 2019promoting Medical & Hospital equipment,Pharmaceutical, Medicine Products, Healthcare prod-ucts, Disposables, Rehabilitation equipment,Miscellaneous Medical Items, Materials for Medicalequipment, and Hospital related supplies will be held atC1-C2 Hall, JIEXPO Kemayoran, Jakarta, Indonesia.For details Contact: Krista Exhibitions, PT.KristomediaPratama, Jalan Blandongan No. 28d/g, Jakarta- 11220,Indonesia. Tel.: +62-21-6340140 and/or 6342113. E-

mail: info@kristamedia.com ; Website: www.indohealth-

careexpo.com London, SW1P 1WG, U.K. Tel.: +44 (0) 20

7017 5000, +971 4 407 2508. E-Mail: tom.coleman@infor-

ma.com, Website:www.medlabasia.com

March 24-27, 2019 Medical Expo 2019 Casablanca,

Morocco. The 20th edition of International Health Fair will beheld at Casablanca International Fair. For details Contact: BHEvents, 314 Bd Abdelmoumen, 1st Floor Apartment No. 4,

Casablanca, Morocco. Tel.:+212- 522991999, 522232309. E-

mail: ibenjelloun@ateliervita.net, Website:www.medical-

expo.ma

March 28-30, 2019 Expomed Eurasia 2019 Istanbul,

Turkey. The 26th edition of expomed eurasia for the medicalindustry, will be held at Istanbul's Tuyap Fair and CongressCenter, Istanbul, Turkey. For details Contact: Reed TuyapFairs Inc., Tuyap Fair & Congress Center Cumburiyet Mah.Eski Hadimkoy Yolu Caddesi 9/4, 34500 Buyukcekmece,

Istanbul, Turkey. Tel.: +90-212-867-1100. E-mail:

expomedistanbul@ e.tuyap.com.tr ; Website:

www.expomedistanbul.com

March 31- April 2, 2019 Rehacare & Orthopedic China

(R&OC 2019) Guangzhow, China. 9th (R&OC) "Rehacare &Orthopedic China (Guangzhow)" will be held inGuangzhou,China. For details Contact: Rehacare & Orthopedic China,F/4, 406, Tower B, Poly World Trade Centre, No.1000 XinGang Dong Road, Haizhu District, Guangzhou, China. Tel.:

+86 20 6622-4913, 6631-8831, E-mail: maggie@cantonre-

hacare.com and/or rehacare@cantonrehacare.com

Website: en.cantonrehacare.com

April 2-4, 2019 AMT 2019 Mishref, Kuwait. Arab MedicalTravel (AMT) along with Kuwait Health, will be held at KuwaitInternational Fairground, Mishref, Kuwait. For detailsContact: Jeano Pangan, (Group Director). Atex InternationalExhibitions, 1610, Opal Tower, Business Bay, POBox 413520, Dubai, UAE. Tel.: +971-4-587-8627,

M: +971-55-198-3448. E-mail: amt@atexinter-

national.com ; Website:www.arabmedicaltrav-

elexhibition.com

April 4-6, 2019 EgyMedica 2019 Cairo- Egypt.

EgyMedica + EgyLabMedicine, exhibition andConferences on Medical and Lab products will beheld in Cairo, Egypt. For details contact: M/sGreenland for Organizing InternationalExhibitions & Conferences, 35, Oboor Building -Salah Salem, Heliopolis - Floor (13) - Cairo,Egypt. Tel.: +202-208-22137, 22109,. Email:

info@egymedica.com Website: www.egymed-

ica.com, www.egylabmedicine.com

April 8-9, 2019 Radiology and Oncology

Congress 2019 Abu Dhabi, U.A.E. The ThirdWorld Congress on Radiology and Oncology withtheme of Practice, Research and leadership willbe held in Abu Dhabi, U.A.E. For Details Contact:Conference Series LLC Ltd., 47,ChurchfieldRoad, London, W3 6AY, UK. Tel.: +44-

2 0 8 8 1 9 0 7 7 4 . E - m a i l :

oncologyradiology@mehealthevents.org (For

Attn.:Christina Williams, Program Manager.). Web.:

https://radiologyoncology.annualcongress.com

April 8-10, 2019 Human Genetics Meet 2019 Abu Dhabi,

U.A.E. 6th World Congress on Human Genetics and GeneticDiseases will be held in Abu Dhabi, U.A.E. For detailsContact: Stella Anderson, Program Manager, Human

Genetics Meet 2019, 47 Churchfield Road, London,W3 6AY, United Kingdom. Tel.: +44-2088190774. E-

mail: humangeneticsmeet2018@gmail.com Web.:

h t t p s : / / w w w . h u m a n g e n e t i c s .

geneticconferences.com

April 11-14, 2019 IDEX 2019 Istanbul, Turkey. 16thIstanbul Dental Equipment and Materials Exhibitionwill be held at CNR Expo Fair Center Yesilkoy,Istanbul, Turkey. For details Contact: Erdem Taylanli(Fairs Group Manager). CNR HOLDING A.S. CnrEkspo Fuar, Merkezi, Yesilköy, Bakirköy, Istanbul. Tic.Odasi, Istanbul Ticaret Odasi. Tic. Sicil No: 530508 /478090. Vergi Dairesi, Bakirköy, Vergi No.: 211-0488676. Tel.: +90-212-465-74-74, E-

Mail:info@cnrholding.com ; Website:

http://cnrholding.com and/or http://cnridex.com

April 13-14, 2019 Dental Lab Expo & Conference 2019

Hyderabad, India. The 3rd International Dental Lab Expo &Conference (IDLEC) an Exclusive Event on Dental LaboratorySegment will be held at HITEX Exhibition Centre, Hitec City,Hyderabad, India. For details Contact: Ivory Exhibitions &Conferences, F-41B, Ground Floor, Barkat Apartment,Shaheen Bagh, Abul Fazal Enclave-2, Okhla, New Delhi-110025. Tel.: +91-11-2694-1512, and/or +91-92125-82184.

E-Mail:ivoryindiacorp@gmail.com ; Web.:

http://www.dentallab-

expo.com

April 16-18, 2019 TIHE

2019 Tashkent,

Uzbekistan. The 24thInternational event TIHEhas been Uzbekistan'smain medical exhibition.It is the only medicalexhibition in Uzbekistanapproved by UFI. Theevent will be held atUzexpo Centre,Tashkent, Uzbekistan.For details Contact: ITEUzbekistan, 3rd Floor,59A, Mustakillik Avenue,Ta s h k e n t - 1 0 0 0 0 0 ,Uzbekistan. Tel.: +998-

7 1 - 1 1 3 - 0 1 8 0 ,

EMail:post@ite-uzbek-

istan.uz Website:

www.tihe.uz

April 16-19, 2019 Korea Lab 2019 Kintex 1, Korea. 13thKorea's International Laboratory, Analytical equipment andBiotechnology Exhibition will be held at Kintex, 1, Korea. Fordetails Contact: Kyungyon Exhibition Corp., Rm 501,Geumsan bldg., 750 Gukhoedaero, Yeongdeungpogu, Seoul,Korea. Tel.: +82-2-785-4771, E-Mail:

hylee@kyungyon.co.kr and/or jihyeseo@kyungyon.co.kr

Website: www.korealab.org

April 17-18, 2019 Bacteriology 2019 Amsterdam,

Netherlands. World conference on Bacteriology andinfections Diseases will be held in Amsterdam,Netherlands. For details Contact: Pulsus Group, 40Bloomsbury Way, London, UK WC1A 2SE. Tel.: 408-429-

2646. E-mail: bacteriology@pulsusevents.org (For

Attn. Kiranmai N, Program Manager). Website: https://

bacteriology.pulsusconference.com

AUTHORIZED DISTRIBUTORS OF ADR Book

Location Shop Name Contact No.

Agra Satish Book Enterprises 9997877123

Allahabad Friends Book Depot 9451743891

Amritsar Rajat Book corner 9417381838

Amritsar Sunder Book Depot 9814074241

Barnala Navchetan Book Shop 9779050692

Dhule Kushal Book shop 9423916592

Dimapur Modern Book Depot 9436006701

Gwalior Unique Book Depot 9826257932

Haldwani Pooram & Sons 9837092823

Jodhpur Book World 9829088088

Kolkata Medicare Book House 9830518610

Muzaffarnagar Royal Pustak Bhandar 9761313181

Nanded Debdhar Pustak Bhandar 9423615127

Nashik Rahul Book Center 0253-2599608

Patna Current Book Services 9431077745

Raipur Srishti Medical Book House 9300855027

Reewa Palak Medical Book 9893793577

Tinsukia Sharma Book Stall 9435036146

Vishakhapatnam Andhra Medical Book Centar 9985716032

For ADR Booking Poonam Singhal,No.-

Mob.- 09219444474.

FORTH COMING EVENTS

dSls ik,a xgjh uhan] vPNhuhan vkus ds 4 mik;

vPNh uhan ds fy, u fliQZ vkidk Lyhios;j vgeHkwfedk fuHkkrk gS] cfYd blds fy, ruko eqÙkQ gksukHkh t:jh gS- vPNh uhan ds lkFk vkidh Ropk fjtwfousVgksrh gS- vkjkenk;d uhan ds fy, Hkkstu ,d egRoiw.kZHkwfedk fuHkkrk gS- fo'ks"kKksa dk dguk gS fd •kus ijè;ku nsdj vPNh uhan yh tk ldrh gS- cknke] dhoh]v•jksV] dsyk] dkcqyh puk] nw/] nfy;k vkSj pkoy ,sls•k| inkFkZ gSa tks uhan c<+kus esa lgk;d gksrs gSa- ^laMseSVªsl* ds laLFkkid vkSj eq[; dk;Zdkjh vf/dkjhvYiQksal jsîóh rFkk ^flLyks dSiQs* ds jlksbZ fo'ks"kKe`uekW; vkpk;Z us Hkkstu vkSj csgrj uhan esa lgk;d vkSj

vklkuh ls cuus okys Hkkstu ij vius fopkj lk>k fd, gSa- blds vykok vki dqN mik;ksa dks viukdj Hkh xgjh uhan ik ldrs gSa- vPNh uhan vkusds 4 mik;%& 1- LdSYi dks ,slh pht dh lgk;rk ls gkbMªsVsM j•uk csgn t:jh gS] tks bls iks"k.k çnku djrk gks- fu;fer :i ls fd;k x;kVªhVesaV ckyksa ds MSest daVªksy esa vge Hkwfedk fuHkkrk gS vkSj vkidks :•s o nks eq¡gs ckyksa ls NqVdkjk fnykrk gS- csgrj gs;j VªhVesaV vkSj lSfVulkWÝV rfd, ds bLrseky ls uhan vPNh vkrh gS- 2- ruko dks de djus o vPNh uhan ds fy, ckyksa dks ck¡/dj ywt twM+k cuk ysa ;k <hyh pksVhcuk ysa- 3- Vh Vªh vkW;y ls fu;fer :i ls flj dh ekfy'k djus ls jÙkQ ifjlapj.k Bhd jgrk gS vkSj cky LoLFk jgus ds lkFk gh ruko ls HkhNqVdkjk feyrk gS- ckyksa dks iks"k.k feyrk gS- gYds gkFkksa ls flj dk elkt djus ls vPNh uhan vkrh gS- 4- jkr esa lksrs le; LVkbfy'k vkSjvkjkenk;d Lyhios;j igusa- lnZ jkrksa ds fy, lSfVu diM+s okyk Lyhios;j mi;qÙkQ jgsxk- vki jaxhu o csgrjhu fçaV okys Lyhios;j igu ldrh gSa-

Wockhardt Receives USFDA Approval For

Prostate Cancer DrugM u m b a i : -Pharmaceut icaland biotechnologymajor WockhardtM o b : -0 9 9 2 7 1 0 6 6 6 8 ,

09922890687, 09530080315, 9818669406,09911529629, 09425170032 has receivedapproval from the United States Food &Drug Administration (US FDA) for an ANDAfor 250mg tablet of Abiraterone acetate,which is used to treat Prostate Cancer.Wockhardt’s Abiraterone acetate tablet is ageneric version of Zytiga®, marketed inUSA and other countries by Johnson &Johnson. Abiraterone is used to treat menwith prostate cancer that has spread toother parts of the body. According to IQVIADecember 2018 data, the product has salesof $1.26 billion in the US. “This is one moreproduct in Wockhardt’s growing portfolio ofoncology products in the US and has sever-al pending ANDA’s for oncology products”said Dr. Habil Khorakiwala, WockhardtFounder Chairman and Group CEO. “Alongwith oncology products, specialty productsremain a focus area for our US businessand for creating a sustainable growth world-wide” he said. Wockhardt will be launchingthis product in the United States, in a shortperiod of time. With its nationwide distribu-tion network and its excellent relationshipwith all major trade, retail and institutionalcustomers, Wockhardt is already a signifi-cant player in the US pharmaceutical mar-

ket. The product is being manufac-tured at a contract manufacturing facil-ity, based near Hyderabad, India.

Intas Pharmaceuticals Acquires The Generics Business of Actavis inThe UK & Ireland

• Establishes Accord as a leading player in the UK generics market • Compelling strate-gic fit and increased access to UK and Irish retail and hospital markets • Expands UKmanufacturing presence with the addition of the high quality Barnstaple site in NorthDevon • More than doubles Intas’ pan-European operations, with pro-forma revenuesexceeding $500m • Intas will become a top 20 generics player globally • Transactiondue to complete in the next three months, subject only to regulatory approvals Intas

Pharmaceuticals Ltd. Mob:- 09927857406, 09450294951 (“Intas”), through its whollyowned subsidiary Accord Healthcare Ltd. (“Accord”), announced today that it has

entered into definitive agreements to acquire Actavis UK Ltd. & Actavis Ireland Ltd. (“Actavis UK & Ireland”) from TevaPharmaceutical Industries Ltd. (“Teva”) for an enterprise value of approximately £600 million payable in cash. The trans-action is part of the European Commission’santi-trust divestiture requirements arising fromTeva’s acquisition of Actavis Generics. Actavis UK& Ireland is one of the leading suppliers of genericpharmaceuticals in both the UK and Irish markets withselected assets and operations across therespective markets. The company focuses on provid-ing high quality generic products to both pharmaciesand wholesalers in the UK & Ireland through itsstrong employee base of over 600 staff. Actavis UK &Ireland is supported by a strong manufacturing pres-ence in the UK through its Barnstaple site, which pro-vides services both to Actavis UK and Ireland andother third parties. The company generated over£250m of sales in 2015. “This transaction representsa unique opportunity for Intas to build scale in the UK& Ireland - adding to our market leading hospital fran-chise - and creates a strong platform for furtherEuropean expansion” says Mr Binish Chudgar, ViceChairman and Managing Director of Intas. “Throughour subsidiary, Accord Healthcare, we have beenoperating successfully in Europe for more than adecade and this acquisi- tion will make Accord a lead-ing generics player in the UK market. We have a clearplan for the continuation and development of theBarnstaple site and the Actavis UK and Ireland team;we look forward to wel- coming them to the IntasGroup. We are confident that the cultural alignment between Accord and Actavis UK & Ireland will ensure a smooth inte-gration.” “Together we have a great opportunity to build on the strong foundations of our respective organisations; weare excited to join the Intas / Accord family and look forward to an exciting future together” says Sara Vincent, ActavisSVP UK and Ireland. This transaction builds on Accord’s commitment to UK manufacturing having recently made a sig-nificant investment to reinstate a facility closed by Sanofi Aventis in Newcastle. The Barnstaple plant will become thecompany’s 4th UK site, ensuring Accord has one of the most extensive local supply chains to service pharmacies, hos-pitals and wholesalers across the UK and Ireland and also into Europe. The transaction is only subject to regulatoryapproval, which is expected to be provided in the next three months, with completion following shortly thereafter.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds tks fd iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj ds uke ls gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsa-

www.medicaldarpan.com

Cipla Receives Final Approval For Generic Version Of EliLilly & Co.’s Adcirca® (Tadalafil Tablets 20mg)

Mumbai:- Cipla Limited Mob:- 09997246756, 09536897006,

09838204444 announced that it has received final approval for its

Abbreviated New Drug Application (ANDA) for Tadalafil Tablets 20mg

from the United States Food and Drug Administration (US FDA). Cipla’s

Tadalafil Tablets 20mg is AB-rated generic therapeutic equivalent version

of Eli Lilly & Co.’s Adcirca ®. It is a phosphodiesterase 5 (PDE5) inhibitor

indicated for the treatment of pulmonary arterial hypertension (PAH)

(WHO Group 1) to improve exercise ability. According to IQVIA (IMS

Health), Adcirca® and its generic equivalents had US sales of approximately $490M for the

12-month period ending November 2018. The product is available for shipping immediately.

Alembic Pharmaceuticals Announces USFDA Approval ForMoxifloxacin Ophthalmic Solution USP 1 0.5%

Alembic Pharmaceuticals Limited (Alembic) Mob:-

09759010968, 09358050732, 08650502909, 09958945666

announced it has received approval from the US Food & Drug

Administration (USFDA) for its Abbreviated New Drug

Application (ANDA) Moxifloxacin Ophthalmic Solution USP,

0.5%. The approved ANDA is therapeutically equivalent to the

reference listed drug product (RLD) Vigamox Ophthalmic Solution USP, 0.5%, of Novartis

Pharmaceuticals Corporation. Moxifloxacin Ophthalmic Solution USP, 0.5% is indicated for

the treatment of bacterial conjunctivitis caused by susceptible strains of certain organisms.

Moxifloxacin Ophthalmic Solution USP, 0.5% has an estimated market size of US$ 68 mil-

lion for twelve months ending December 2018 according to IQVIA. Alembic has a cumula-

tive total of 86 ANDA approvals (73 final approvals and 13 tentative approvals) from USFDA.

Lupin Receives FDA Approval For Azacitidine For Injection 100 mgSingle-Dose Vial

Mumbai:- Pharma major Lupin Mob:- 09456940669, 09058720074, 09219177868,

09897043043 announced that it has received approval for its Azacitidine for Injection, 100 mgSingle-Dose Vial from the United States Food and Drug Administration (FDA) to market ageneric version of Celgene Corporation's Vidaza®. With this approval, Lupin strengthens itscomplex generics portfolio in Injectables. Lupin's Azacitidine for Injection, 100 mg Single-Dose Vial is a generic version of Celgene Corporation's Vidaza®. It is indicated for treatmentof patients with the following French-American-British (FAB) myelodysplastic syndrome sub-types: refractory anemia (RA) or refractory anemia with ringed sideroblasts (if accompaniedby neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excessblasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chron-ic myelomonocytic leukemia (CMMoL). Azacitidine for Injection, 100 mg Single-Dose Vial had

annual sales of approximately USD 112 million in the US (IQVIA MAT December 2018). Lupin's state-of-the-artMihan facility at Nagpur commissioned recently has the production capabilities for injectables with vials,Iyophilised vials and Pre-filled Syringes (PFS). It received an EIR from US FDA in December 2018.

fudq¡t Lokeh dh vksj ls czts'k dqekj xxZ }kjk izdkf'kr] czts'k dqekj xxZ }kjk eqfær rFkk U;w fizUV bafM;k] lkfgckckn esa eqfær ,oa ch0,u0 eSMhdy dkWEIySDl] cqyUn'kgj ls izdkf'kr lEiknd& czts'k dqekj xxZ

ww

w.m

ed

ica

ldarp

an

.co

m

Wo

rk M

ore

, Alw

ay

s S

mile

.

eg¡xh ugha fcdsaxh dSlj dh nok,a] nqyZHk chekjh;ksa ij Hkh iQSlyk tYneg¡xh nokvkssa ds f[kykiQ ,d ckj fiQj dsaUnz ljdkj us l[r dne mBk;k gS- jk"Vªh; vkS"kf/ ewY; fu/kZj.k fu;ked (,uihih,)us cq/okj dks rhu vge iQSlys fy,- bues 42 rjg dh dSalj fujks/d nokb;ksa ds ewY; fu;a=k.k ds nk;js esa 'kkfey djus dkiQSlyk Hkh gS- vc bu nokvksa ij daifu;k¡ 8 ekpZ ds ckn 30 iQhlnh ls T;knk equkiQk ugha dek ik,axh- crk ns fd dSljdh 57 nok,a igys ls gh lwphc¼ iQkE;Zwys'ku ds rgr ewY; fu;a=k.k ds nk;js essa 'kkfey gSa- lkFk gh 38 nqyZHk chekjh;kas dhnok dks Hkh tYn gh fu;a=k.k esa yk;k tk,xk- ,uihih, us dSalj] e/qesg] jDrpki] laØe.k nnZ] vLFkek lfgr 36 rjg dhnokvksa dh dher ij Hkh vkS"kf/ dher fu;a=k.k vkns'k 2013 (Mhihlhvks) ds rgr fu;a=k.k fd;k gS- gkyafd ,uihih us nokfuekZrk daifu;kas dks fiQygky dqN fnuksa dk oDr fn;k gS- ubZ dhersa 8 ekpZ 2019 ls ykxw dh tk,axh- lHkh vkS"kf/ fuekZrkvksssadks lkr fnu ds vanj vius [kqnjk ewY;ksa esa cnyko ewY;ksa esa cnyko dj ysus dks dgk x;k gS- bldh tkudkjh ,uih,, dslkFk gh jkT; nok fu;a=kdksa] Fkksd nok O;kikfj;ksa vkSj [kqnjk nok O;kikfj;ksa dks Hkh nsus dss fy, dgk x;k gS-